2026 NPPES data Pulmonary Disease Physician NPI 1427509611 N.P.
Verify on CMS →

SUPINDER CHANNA, N.P.

Pulmonary Disease Physician in SPARTANBURG, South Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 628 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
33%
generic claims · 67% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.7988/100
▼ 0 pts below national avg 83.1 · [object Object]
Industry payments
$1.7K
78 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SUPINDER CHANNA, N.P. reported a CMS MIPS final score of 82.7988/100 — below the 83.1 national average — and filed 3,611 Medicare Part D claims in 2023.

82.7988/100
MIPS score · 0 vs avg
4K
Part D claims, 2023
33%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SUPINDER CHANNA, N.P.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

83 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SUPINDER CHANNA, N.P. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SUPINDER CHANNA, N.P.?

Near national average

NPI registry status

Active

Issued 10/22/2016

NPI 1427509611

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

3,611 148% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

82.7988/100 0.30119999999999436% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in South Carolina

How Pulmonary Disease Physician compares to other specialties among South Carolina providers

South Carolina providers

Pulmonary Disease Physician share within South Carolina

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within South Carolina

Medicare quality performance — MIPS

SUPINDER CHANNA, N.P.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

Near national average
MIPS Final Score
82.7988/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 82.7988/100 vs national avg 83.1

0%100%National avg83%82.8%
MIPS final score (Pulmonary Disease Physician) — 82.7988/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SUPINDER CHANNA, N.P. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding N.P. credentials at 151 HAROLD FLEMING CT, SPARTANBURG, SC, 29303, with a listed phone of (864) 573-6320. NPI 1427509611 was issued on 10/22/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHANNA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,611 prescription claims written by this provider, covering 628 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 67% brand-name and 33% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.7988/100 for the 2023 performance year (Quality 92.6524, Cost 50.0102), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

151 HAROLD FLEMING CT
SPARTANBURG, SC 29303

Provider Details

NPI 1427509611
Specialty Pulmonary Disease Physician
Credentials N.P.
Gender Female
NPI Issued 10/22/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.7988
Final Score
Avg: 83.1
92.6524
Quality
50.0102
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SUPINDER CHANNA, N.P. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UPSTATE LUNG AND CRITICAL CARE SPECIALISTS PC
SPARTANBURG, SC

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUPINDER CHANNA, N.P.. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

Actelion Pharmaceuticals US, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

SUPINDER CHANNA, N.P. — brand share 67.0%
Specialty average (est.)

67% brand-name claims vs 33% generic, on 3,611 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,611
Total Claims
$1.5M
Total Drug Cost
628
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,501
Total Day Supply
121,497
Brand vs Generic
67% brand / 33% generic
Brand Drug Cost
$1.5M
Antibiotic Claims
115

Patient Demographics

Average Patient Age
70.2 years
Avg HCC Risk Score
1.86
Gender Split
64% female / 36% male
Age Distribution
<65: 138, 65-74: 288, 75-84: 175, 85+: 27

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SUPINDER CHANNA, N.P. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
1,060
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
617
Prednisone
225
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
215
Breo Ellipta
Fluticasone/Vilanterol
209
Stiolto Respimat
Tiotropium Br/Olodaterol Hcl
188
Montelukast Sodium
148
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
129
Symbicort
Budesonide/Formoterol Fumarate
107
Ventolin Hfa
Albuterol Sulfate
89

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How SUPINDER CHANNA, N.P. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

SUPINDER CHANNA, N.P.'s 3,611 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in South Carolina

Other clinicians with the same primary specialty enrolled in South Carolina, drawn from the same CMS NPPES roster as CHANNA.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SUPINDER CHANNA, N.P.'s specialty?
SUPINDER CHANNA, N.P. specializes in Pulmonary Disease Physician and practices in SPARTANBURG, South Carolina. Credentials: N.P..
How much does SUPINDER CHANNA, N.P. prescribe under Medicare Part D?
In 2023, SUPINDER CHANNA, N.P. wrote 3,611 Medicare Part D claims totaling $1.5M in drug costs for 628 beneficiaries.
What is SUPINDER CHANNA, N.P.'s Medicare quality score?
SUPINDER CHANNA, N.P. has a CMS MIPS Final Score of 82.7988/100 (Quality: 92.6524, Cost: 50.0102). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SUPINDER CHANNA, N.P. located?
SUPINDER CHANNA, N.P. is located at 151 HAROLD FLEMING CT, SPARTANBURG, SC, 29303. Phone: (864) 573-6320.
What is SUPINDER CHANNA, N.P.'s NPI number?
SUPINDER CHANNA, N.P.'s National Provider Identifier (NPI) is 1427509611, issued on 10/22/2016.
Does SUPINDER CHANNA, N.P. prescribe more brand-name or generic drugs?
SUPINDER CHANNA, N.P.'s prescribing is 67% brand-name and 33% generic drugs by claim count, with $1.5M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does SUPINDER CHANNA, N.P. prescribe most often?
Based on 2023 Medicare Part D data, SUPINDER CHANNA, N.P.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Trelegy Ellipta, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SUPINDER CHANNA, N.P. accept Medicare?
SUPINDER CHANNA, N.P. appears in CMS Medicare data with 3,611 Part D claims and 628 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SUPINDER CHANNA, N.P.'s credentials?
SUPINDER CHANNA, N.P.'s NPI is 1427509611 with credentials N.P.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology